Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 66885 | 11.14 |
09:34 ET | 3992 | 11.02 |
09:36 ET | 4533 | 10.96 |
09:38 ET | 2900 | 10.96 |
09:39 ET | 849 | 10.93 |
09:41 ET | 1833 | 10.86 |
09:43 ET | 13035 | 10.77 |
09:45 ET | 11657 | 10.86 |
09:48 ET | 2838 | 10.8 |
09:50 ET | 944 | 10.82 |
09:52 ET | 1045 | 10.79 |
09:54 ET | 745 | 10.76 |
09:56 ET | 31523 | 10.7 |
09:57 ET | 1392 | 10.73 |
09:59 ET | 1394 | 10.7 |
10:01 ET | 892 | 10.69 |
10:03 ET | 1376 | 10.66 |
10:06 ET | 100 | 10.66 |
10:08 ET | 1110 | 10.6 |
10:10 ET | 3460 | 10.61 |
10:12 ET | 1293 | 10.57 |
10:14 ET | 9222 | 10.65 |
10:15 ET | 3238 | 10.655 |
10:17 ET | 10289 | 10.615 |
10:19 ET | 4700 | 10.55 |
10:21 ET | 2673 | 10.525 |
10:24 ET | 8997 | 10.505 |
10:26 ET | 107716 | 10.55 |
10:28 ET | 2476 | 10.57 |
10:30 ET | 4444 | 10.5506 |
10:32 ET | 3386 | 10.62 |
10:33 ET | 5052 | 10.58 |
10:35 ET | 1306 | 10.61 |
10:39 ET | 2815 | 10.62 |
10:42 ET | 954 | 10.5985 |
10:44 ET | 655 | 10.545 |
10:46 ET | 770 | 10.53 |
10:48 ET | 3212 | 10.49 |
10:50 ET | 2000 | 10.48 |
10:51 ET | 700 | 10.48 |
10:53 ET | 1408 | 10.49 |
10:55 ET | 1595 | 10.51 |
10:57 ET | 900 | 10.52 |
11:00 ET | 748 | 10.53 |
11:02 ET | 500 | 10.56 |
11:04 ET | 9809 | 10.61 |
11:06 ET | 1831 | 10.61 |
11:08 ET | 2700 | 10.6 |
11:09 ET | 200 | 10.6 |
11:13 ET | 1430 | 10.56 |
11:15 ET | 800 | 10.58 |
11:18 ET | 3100 | 10.605 |
11:20 ET | 2556 | 10.605 |
11:22 ET | 300 | 10.6001 |
11:24 ET | 2785 | 10.6 |
11:26 ET | 100 | 10.5962 |
11:27 ET | 200 | 10.59 |
11:29 ET | 200 | 10.59 |
11:31 ET | 10773 | 10.62 |
11:33 ET | 242 | 10.62 |
11:36 ET | 200 | 10.62 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.5B | -2.6x | --- |
Immatics NV | 1.3B | -12.7x | --- |
Arcus Biosciences Inc | 1.5B | -5.1x | --- |
Ardelyx Inc | 1.5B | -23.6x | --- |
Arvinas Inc | 1.8B | -4.6x | --- |
Prothena Corporation PLC | 1.1B | -6.7x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.50 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 19.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.